These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32925910)

  • 21. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
    Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
    Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.
    Vizzi E; Bastidas G; Hidalgo M; Colman L; Pérez HA
    Malar J; 2016 Jan; 15():19. PubMed ID: 26753754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination.
    Han KT; Han ZY; Aye KH; Wai KT; Thi A; Cui L; Sattabongkot J
    Trop Med Health; 2021 Jun; 49(1):47. PubMed ID: 34108049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G6PD deficiency in Latin America: systematic review on prevalence and variants.
    Monteiro WM; Val FF; Siqueira AM; Franca GP; Sampaio VS; Melo GC; Almeida AC; Brito MA; Peixoto HM; Fuller D; Bassat Q; Romero GA; Maria Regina F O; Marcus Vinícius G L
    Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):553-68. PubMed ID: 25141282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
    Lover AA; Dantzer E; Hongvanthong B; Chindavongsa K; Welty S; Reza T; Khim N; Menard D; Bennett A
    Malar J; 2018 Jun; 17(1):218. PubMed ID: 29859089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
    Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
    Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
    Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tafenoquine and G6PD: a primer for clinicians.
    Chu CS; Freedman DO
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30941413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria.
    Ley B; Alam MS; Satyagraha AW; Phru CS; Thriemer K; Tadesse D; Shibiru T; Hailu A; Kibria MG; Hossain MS; Rahmat H; Poespoprodjo JR; Khan WA; Simpson JA; Price RN
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010406. PubMed ID: 35544453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
    Peixoto HM; Brito MA; Romero GA; Monteiro WM; de Lacerda MV; de Oliveira MR
    Malar J; 2016 Feb; 15():82. PubMed ID: 26864333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G6PD deficiency in malaria endemic areas of Nepal.
    Marasini B; Lal BK; Thapa S; Awasthi KR; Bajracharya B; Khanal P; Neupane S; Jha SN; Acharya S; Iama S; Koirala M; Koirala D; Bhandari S; Mahato RK; Chaudhary A; Ghimire P; Magar RG; Bhattarai RK; Gornsawun G; Penpitchaporn P; Bancone G; Acharya BP
    Malar J; 2020 Aug; 19(1):287. PubMed ID: 32787970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
    Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
    PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
    Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
    Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Field evaluation of a novel semi-quantitative point-of-care diagnostic for G6PD deficiency in Indonesia.
    Sadhewa A; Panggalo LV; Nanine I; Price RN; Thriemer K; Satyagraha AW; Ley B
    PLoS One; 2024; 19(4):e0301506. PubMed ID: 38687748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
    Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples.
    Zúñiga MÁ; Mejía RE; Sánchez AL; Sosa-Ochoa WH; Fontecha GA
    Malar J; 2015 Aug; 14():308. PubMed ID: 26249834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.
    Carter N; Pamba A; Duparc S; Waitumbi JN
    Malar J; 2011 Aug; 10():241. PubMed ID: 21849081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
    Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
    PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.
    Aung TH; Suansomjit C; Tun ZM; Hlaing TM; Kaewkungwal J; Cui L; Sattabongkot J; Roobsoong W
    Malar J; 2023 May; 22(1):143. PubMed ID: 37127600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose-6-phosphate dehydrogenase activity measured by spectrophotometry and associated genetic variants from the Oromiya zone, Ethiopia.
    Kießling N; Brintrup J; Zeynudin A; Abduselam N; Götz S; Mack M; Pritsch M; Wieser A; Kohne E; Berens-Riha N
    Malar J; 2018 Oct; 17(1):358. PubMed ID: 30314477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.